A gene that scientific dogma insists is inactive in adults actually plays a vital role in preventing the underlying cause of most heart attacks and strokes, researchers at the University of Virginia School of Medicine have determined. The discovery opens a new avenue for battling those deadly conditions, and it raises the tantalizing prospect that doctors could use the gene to prevent or delay at least some of the effects of aging.
“Finding a way to augment the expression of this gene in adult cells may have profound implications for promoting health and possibly reversing some of the detrimental effects with aging,” said researcher Gary K. Owens, PhD, director of UVA’s Robert M. Berne Cardiovascular Research Center.
Unexpected Protective Effect
The gene, Oct4, plays a key role in the development of all living organisms, but scientists have, until now, thought it was permanently inactivated after embryonic development. Some controversial studies have suggested it might have another function later in life, but the UVA researchers are the first to provide conclusive evidence of that: Owens and his colleagues have determined the gene plays a critical protective role during the formation of atherosclerotic plaques inside blood vessels. The rupturing of these plaques is the underlying cause of many heart attacks and strokes.
The researchers found that Oct4 controls the movement of smooth muscle cells into protective fibrous “caps” inside the plaques – caps that make the plaques less likely to rupture. The researchers also have provided evidence that the gene promotes many changes in gene expression that are beneficial in stabilizing the plaques.
This is exciting, because studies suggest that it may be possible to develop drugs or other therapeutic agents that target the Oct4 pathway as a means to reduce the incidence of heart attacks or stroke. “Our findings have major implications regarding possible novel therapeutic approaches for promoting stabilization of atherosclerotic plaques,” said Olga A. Cherepanova, PhD, a senior research scientist in Owens’ lab.
One surprising finding from UVA’s research: When the researchers blocked the effect of Oct4 in mice, they thought the atherosclerotic plaques might become smaller, because of the reduced number of smooth muscle cells inside. Instead, the plaques grew larger, less stable and more dangerous, stuffed with lipids, dead cells and other damaging components.
Advancing Regenerative Medicine
While UVA’s research has focused on how Oct4 offers cardiovascular protection, Owens and his colleagues believe the gene could also prove critical to the field of regenerative medicine, which investigates the growth and replacement of tissues and organs. The researchers believe that Oct4 and its family of target genes are activated in other somatic cells – the non-reproductive cells in the body – and play a key role in the cells’ ability to repair damage and heal wounds. Studies to test this are under way in Owens’ lab.
Oct4 is one of the “stem cell pluripotency factors” described by Shinya Yamanaka, MD, PhD, for which he received the 2012 Nobel Prize. His lab and many others have shown that artificial over-expression of Oct4 within somatic cells grown in a lab dish is essential for reprogramming these cells into induced pluripotential stem cells, which can then develop into any cell type in the body or even an entire organism.
The UVA researchers suspect that at least some of the detrimental effects of aging, including the increased possibility of a plaque rupture, stem from a decrease in the body’s ability to reactivate Oct4. “Finding a way to reactivate this pathway may have profound implications for health and aging,” Owens said. “We think this is just the tip of the iceberg for controlling plasticity of somatic cells, and this could impact many human diseases and the field of regenerative medicine. Who knows, this may end up being the ‘fountain-of-youth gene,’ a way to revitalize old and worn-out cells. Only time will tell.”
The Latest on: Oct4 gene
via Google News
The Latest on: Oct4 gene
- Study finds gene associated with twin pregnancy on October 11, 2018 at 11:14 pm
the study was conducted by Shenzhen-based Beijing Genomics Institute and published in the international academic journal Cell on Oct 4. The team analyzed two traits - maternal age and twin pregnancy, ... […]
- Gene Hardin - Death Notice on October 5, 2018 at 10:57 pm
Disclaimer: The addresses mapped on this page are provided by the respective organizations listed in the notice, NewsOK is not responsible for mismapped or bad location information. Please verify all ... […]
- Scientists Create First Stem Cells Using CRISPR Technology on January 20, 2018 at 6:36 am
The researchers targeted two genes that are only expressed in stem cells and known to be integral to pluripotency: Sox2 and Oct4. Like transcription factors, these genes turn on other stem cell genes ... […]
- UK gene editing breakthrough could land an Aussie in jail for 15 years: here’s why our laws need to catch up on September 25, 2017 at 8:37 pm
Niakan’s team showed that one particular gene, “OCT4”, plays a key role. They used the CRISPR-CAS9 system – which allows researchers to make precise changes to DNA sequences - to turn off the OCT4 gen... […]
- Gene editing of human embryos in UK reveals new fertility clue on September 21, 2017 at 1:27 pm
The team used a gene-editing technique known as CRISPR-Cas9 to switch off a particular gene involved in embryo development known as OCT4. Blocking the functioning of the gene means the resulting prote... […]
- Genome editing reveals key gene for human embryo growth on September 20, 2017 at 11:50 am
They used genome "scissors" called CRISPR-Cas9 to snip out a gene called OCT4 from fertilised eggs. OCT4 is thought to be a major player in embryo formation. "After the egg is fertilised, it divides u... […]
- Scientists Edit Embryos with CRISPR to Better Understand Early Human Development on September 20, 2017 at 11:06 am
A new study carried out at the Francis Crick Institute has established the crucial role a gene that produces the protein OCT4 plays in the early stages of human development. By editing the genome, res... […]
- Researchers are Now Editing Genomes of Human Embryos on September 20, 2017 at 10:57 am
Niakan focused on this certain gene, called Oct4, because previous work on mouse embryos showed that it was an essential gene for development of the mouse. When Niakan removed the gene in the human em... […]
- Gene key for chemically reprogramming human stem cells on January 26, 2017 at 9:02 am
Scientists have discovered the gene essential for chemically reprogramming human amniotic stem cells into a more versatile ... The study, published today in Molecular Therapy, found that the OCT4 gene ... […]
via Bing News